Legacy Wealth Asset Management, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.

Quarter-by-quarter ownership
Legacy Wealth Asset Management, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2023$119,080
+27.9%
13,0000.0%0.04%
+22.9%
Q4 2022$93,080
+43.2%
13,0000.0%0.04%
+25.0%
Q3 2022$65,000
+103.1%
13,0000.0%0.03%
+115.4%
Q2 2022$32,000
-64.0%
13,0000.0%0.01%
-59.4%
Q1 2022$89,000
-15.2%
13,0000.0%0.03%
-11.1%
Q4 2021$105,000
-17.3%
13,0000.0%0.04%
-37.9%
Q3 2021$127,000
+46.0%
13,0000.0%0.06%
+48.7%
Q2 2021$87,00013,0000.04%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,102,673$4,468,0000.92%
JW Asset Management, LLC 444,439$640,0000.33%
BRANDES INVESTMENT PARTNERS, LP 7,052,720$10,157,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,722,241$3,920,0000.15%
Tekla Capital Management LLC 814,588$1,173,0000.05%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 34,750$50,0000.04%
Brown Capital Management 1,400,007$2,016,0000.02%
ACADIAN ASSET MANAGEMENT LLC 843,975$1,217,0000.01%
WEDBUSH SECURITIES INC 35,535$51,0000.01%
Close Asset Management Ltd 15,000$22,0000.00%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders